These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3241326)

  • 21. [Basic and clinical studies of sulbactam/cefoperazone in pediatric field].
    Haruta T; Ohkura K; Kuroki S; Kobayashi Y
    Jpn J Antibiot; 1984 Oct; 37(10):1893-7. PubMed ID: 6094867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1984 Oct; 37(10):1880-92. PubMed ID: 6094866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental and clinical studies of sulbactam/cefoperazone in pediatric field].
    Nakashima T; Ueda S; Hayakawa F; Miyachi Y; Hakamada S; Kuno K
    Jpn J Antibiot; 1984 Oct; 37(10):1846-58. PubMed ID: 6094864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
    Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa].
    Niida M; Yoshida T; Kohmoto A; Ogawa M; Hashimoto H; Deguchi K
    Jpn J Antibiot; 1994 Jan; 47(1):1-10. PubMed ID: 8114267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of sulbactam/cefoperazone in the pediatric infections].
    Meguro H; Tajima T; Nonaka C; Mashiko J; Fujii R; Arimasu O
    Jpn J Antibiot; 1984 Oct; 37(10):1821-30. PubMed ID: 6094862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Nakamura H; Iwata Y; Hayashi S
    Jpn J Antibiot; 1984 Oct; 37(10):1956-63. PubMed ID: 6094874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical experience on sulbactam/cefoperazone in the pediatric field].
    Honjo T; Watanabe A
    Jpn J Antibiot; 1984 Oct; 37(10):1788-92. PubMed ID: 6094858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental studies on the pharmacokinetics of cefoperazone (CPZ) injection under burn eschar].
    Han F; Chen B; Fang J
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 May; 11(3):212-5. PubMed ID: 8732031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical assessment of sulbactam/cefoperazone in comparison with ceftizoxime in patients with postoperative infections by well controlled method].
    Yura J; Shinagawa N; Ando M; Ishikawa S; Masaoka A; Kataoka M; Kondo T; Horisawa M; Suzuki H; Iriyama K
    Jpn J Antibiot; 1985 Mar; 38(3):643-70. PubMed ID: 2993690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Passage into the human milk and clinical evaluation of sulbactam/cefoperazone].
    Matsuda S; Kashiwagura T; Hirayama H
    Jpn J Antibiot; 1985 Feb; 38(2):223-9. PubMed ID: 2989572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Obata I; Ryu F; Imagawa N; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1984 Dec; 37(12):2478-94. PubMed ID: 6098741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
    Sukoh M; Inoue T; Morita Y; Ito K; Togano Y; Yamanaka K; Hirose S; Takahashi T; Mita S; Mano K
    Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfer of cefoperazone into human skin fluid.
    Sugiyama H; Hatano T; Takayanagi K; Aoyama H; Goto T
    Clin Ther; 1985; 7(5):607-10. PubMed ID: 4053148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1984 Nov; 37(11):2223-33. PubMed ID: 6098716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transfer of cefotetan into exudates from excoriated skin wounds].
    Sugiyama H; Hatano T; Takayanagi K; Aoyama H; Kikuchi Y
    Jpn J Antibiot; 1986 May; 39(5):1297-301. PubMed ID: 3463777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transfer of cefoperazone into exudate from postoperative wound].
    Yasumoto R; Asakawa M; Kobayakawa H
    Hinyokika Kiyo; 1988 Apr; 34(4):759-62. PubMed ID: 3400555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandins released into human burn blister fluid.
    Sugiyama S; Norimatsu I; Kobayashi M; Ozawa T; Aoyama H; Suzuki K; Izawa Y
    Biomedicine; 1978 Apr; 29(2):51-3. PubMed ID: 667287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.